Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Materia Medica Capital

Status
Global HQ
China
Countries of investment
    Investment stages
      Industries
        About
        Materia Medica Processing is a leading pharmaceutical cannabis company with advanced technology and expertise in cannabinoid chemistry, offering cutting-edge production and quality control services in Italy.
        Min check size
        -
        Max check size
        -
        Fund size
        NPS

        Investment Thesis

        Lead investor
        Co Invest
        Number of exits
        Preferred contact method

        Manager's Experience

        Bringing over two decades of investment experience, the fund manager has successfully navigated various sectors including technology and healthcare across North America and Europe. With a strategic focus on growth-stage companies, they have executed over 30 deals, culminating in several high-profile exits. Their operator-first approach emphasizes collaboration with management teams to drive value creation, while a data-driven analysis informs decision-making processes. This investment philosophy has resulted in a robust portfolio characterized by innovative, scalable businesses.
        Fund number
        Vintage Year
        Net Internal Rate of Return
        Investment Multiple
        Capital Allocation
        Management Fee
        Carried Interest
        AUM
        Follow-on Investments
        Graduation Rate
        Write-Off Ratio
        Last profile update timestamp